Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Clinical and Experimental Immunology
|
July 15, 1999
Depletion of peritoneal CD5+ B cells has no effect on the course of Leishmania major infection in susceptible and resistant mice
B Babai, H Louzir, P A Cazenave, et al.
Infection and Immunity
|
June 18, 2002
Identification of a disulfide isomerase protein of Leishmania major as a putative virulence factor
Y Ben Achour, M Chenik, H Louzir, et al.
Journal of Immunological Methods
|
November 10, 1988
Enzyme immunoassay analysis of antibody specificities present in the circulating immune complexes of selected pathological sera
H Louzir, T Ternynck, Y Gorgi, et al.
Natural Toxins
|
January 1, 1994
Purification from Vipera lebetina (desert adder) venom of a protein that depletes human complement
A Gasmi, H Louzir, H Karoui, et al.
Arthritis and Rheumatism
|
July 13, 2004
Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease
M Ben Ahmed, H Houman, M Miled, et al.
Infection and Immunity
|
July 12, 2001
Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response
C Kébaïer, H Louzir, M Chenik, et al.
Clinical and Experimental Immunology
|
March 1, 1990
IgA polyspecific autoantibodies in IgA nephropathy
P Matsiota, P Dosquet, H Louzir, et al.
Vaccine
|
January 19, 2006
Vaccination with the divergent portion of the protein histone H2B of Leishmania protects susceptible BALB/c mice against a virulent challenge with Leishmania major
M Chenik, H Louzir, H Ksontini, et al.
Clinical Immunology and Immunopathology
|
February 1, 1992
Autoantibodies and circulating immune complexes in sera from patients with hepatitis B virus-related chronic liver disease
H Louzir, T Ternynck, Y Gorgi, et al.
Vaccine
|
December 17, 2009
Cellular and humoral responses induced by Leishmania histone H2B and its divergent and conserved parts in cutaneous and visceral leishmaniasis patients, respectively
A Meddeb-Garnaoui, A Toumi, H Ghelis, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Clinical and Experimental Immunology
|
July 15, 1999
Depletion of peritoneal CD5+ B cells has no effect on the course of Leishmania major infection in susceptible and resistant mice
B Babai, H Louzir, P A Cazenave, et al.
Infection and Immunity
|
June 18, 2002
Identification of a disulfide isomerase protein of Leishmania major as a putative virulence factor
Y Ben Achour, M Chenik, H Louzir, et al.
Journal of Immunological Methods
|
November 10, 1988
Enzyme immunoassay analysis of antibody specificities present in the circulating immune complexes of selected pathological sera
H Louzir, T Ternynck, Y Gorgi, et al.
Natural Toxins
|
January 1, 1994
Purification from Vipera lebetina (desert adder) venom of a protein that depletes human complement
A Gasmi, H Louzir, H Karoui, et al.
Arthritis and Rheumatism
|
July 13, 2004
Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease
M Ben Ahmed, H Houman, M Miled, et al.
Infection and Immunity
|
July 12, 2001
Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response
C Kébaïer, H Louzir, M Chenik, et al.
Clinical and Experimental Immunology
|
March 1, 1990
IgA polyspecific autoantibodies in IgA nephropathy
P Matsiota, P Dosquet, H Louzir, et al.
Vaccine
|
January 19, 2006
Vaccination with the divergent portion of the protein histone H2B of Leishmania protects susceptible BALB/c mice against a virulent challenge with Leishmania major
M Chenik, H Louzir, H Ksontini, et al.
Clinical Immunology and Immunopathology
|
February 1, 1992
Autoantibodies and circulating immune complexes in sera from patients with hepatitis B virus-related chronic liver disease
H Louzir, T Ternynck, Y Gorgi, et al.
Vaccine
|
December 17, 2009
Cellular and humoral responses induced by Leishmania histone H2B and its divergent and conserved parts in cutaneous and visceral leishmaniasis patients, respectively
A Meddeb-Garnaoui, A Toumi, H Ghelis, et al.
Page
of 3